本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Repare Therapeutics Inc.

1.39
+0.02501.84%
成交量:10.40万
成交额:14.48万
市值:5,887.73万
市盈率:-0.69
高:1.42
开:1.39
低:1.37
收:1.36
数据加载中...
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/08

重要事件披露

8-K - Current report
2021/04/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/04

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/04

重要事件披露

8-K - Current report
2021/03/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report
2020/08/13

重要事件披露

8-K - Current report
2020/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/07

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/07/06

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership